QRS MAGNOVIT AG
Founded in 1994, QRS Magnovit AG has been working together with its scientific partner, Prof. Dr. Fischer AG, for more than 30 years in the field of magnetic field technological systems for therapeutic, sports medicine, and private applications.
The core competence of Prof. Dr. Fischer AG is in the development, generation, and precise regulation of electromagnetic fields, frequency patterns, and pulse forms. It also prepares and provides the scientific background.
Based on the establishment of Prof. Dr. Fischer AG, new solutions for medical and technological QRS applications are continuously being developed. QRS Magnovit AG accompanies this development process and, together with its partner, is committed to opening up further meaningful therapeutic application possibilities.
QRS offers (in the low-intensity magnetic field range) a unique pulse form; the so-called E-amplitude. This specifically supports ion transport within the organism and can thereby influence central bioelectrical processes. Since all physiological and biochemical processes in the body are based on electrical charges and ion movements, this mechanism is of fundamental importance.
The QRS doctrine is based on the recognition that the human organism is a highly complex, bioelectrically controlled system whose regulation is closely linked to natural electromagnetic frequency patterns. Technically generated, low-intensity magnetic fields can specifically support and stabilize these processes.
From a medical perspective, QRS pursues a cause-oriented approach. Many health complaints are associated with impaired cellular functions or restricted regulatory mechanisms, for example in the areas of musculature, metabolism, or neuronal control.
This is particularly evident in the field of rehabilitation: functioning regulatory processes are crucial for regeneration, mobility, and sustainable recovery. QRS market position is the one of a complementary component of modern therapeutic approaches with the goal of efficiently accompanying and promoting healing processes.
QRS advises its customers (right in the picture: Michael Gfrerer, QRS MAGNOVIT AG, CEO) with professional expertise.
Our technologies are aimed at supporting these fundamental processes. Especially in the rehabilitative context, where regeneration, restoration of function, and long-term stabilization play a central role.
For us, the highest aim is: to offer solutions that support the organism on a fundamental level, without having to accept the risks of undesirable side effects.
The claim of our QRS products is based on this understanding.
Your QRS Team
